ST Pharm Co.,Ltd. (237690.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap2.45T
Enterprise Value2.5T
P/E Ratio34.78
PEG Ratio0.28
Price/Sales Ratio6.98
Price/Book Ratio3.94
Enterprise/Revenue6.87
Enterprise/EBITDA20.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.2
Operating Margin0.19
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.12

Income Statement

Revenue331.55B
Revenue/Share16,657.53
Gross Profit129.32B
EBITDA84.4B
Net Income54.99B
Diluted EPS2,688.35

Balance Sheet

Total Cash195.29B
Total Cash/Share9,399.21
Total Debt74.33B
Total Debt/Equity0.12
Current Ratio2.08
Book Value Per Share29,419.55

Price History

52-Week Change48.02
52-Week High172,100
52-Week Low76,100
Moving Average 50 Days137,278
Moving Average 200 Days125,714

Statistics

Average Volume141,212
Shares Outstanding20.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield0.43
Payout Ratio0.15
Last Split FactorN/A
Last Split DateN/A
AD